ARTV Artiva Biotherapeutics, Inc.

Fundamentals / CIK 0001817241 / USD

Artiva Biotherapeutics, Inc. reported $0 in revenue and a net loss of $98.11M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ARTV in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

3 fiscal years (2023 to 2025), reported in USD.

$41.87M$20.93M$0-$81.26MFY 2023 Revenue: $33.49MFY 2023 Net Income: -$28.72M2023FY 2024 Revenue: $251KFY 2024 Net Income: -$65.37M2024FY 2025 Revenue: $0FY 2025 Net Income: -$83.86M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31
Revenue $0 $251K $33.49M
Research & Development $69.54M $50.33M $50.25M
Total Operating Expenses $89.81M $67.53M $64.16M
Operating Income -$89.81M -$67.28M -$30.67M
EBITDA -$87.21M -$64.85M -$28.41M
Income Before Tax -- -$65.37M -$28.65M
Income Tax Expense $0 $0 $72K
Net Income -$83.86M -$65.37M -$28.72M
Basic EPS -$3.43 -$5.81 -$35.78
Diluted EPS -$3.43 -$5.81 -$35.78
Basic Shares Outstanding 24.4M 11.3M 802.7K
Diluted Shares Outstanding 24.4M 11.3M 802.7K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue -- -- -- -- -- -- -- $0
Research & Development $25.99M $21.93M $19.31M $16.99M $17.63M $17.86M $17.05M $13.32M
Total Operating Expenses $31.95M $26.89M $24.43M $21.93M $22.90M $22.81M $22.17M $18.27M
Operating Income -$31.95M -$26.89M -$24.43M -$21.93M -$22.90M -$22.81M -$22.17M -$18.27M
EBITDA -$31.20M -$26.20M -$23.76M -$21.27M -$22.23M -$22.17M -$21.54M -$17.65M
Net Income -$28.82M -$25.00M -$23.52M -$20.77M -$21.53M -$21.25M -$20.31M -$16.09M
Basic EPS -$0.56 -$0.63 -$0.95 -- -$0.88 -$0.87 -$0.83 --
Diluted EPS -$0.56 -$0.63 -$0.95 -- -$0.88 -$0.87 -$0.83 --
Basic Shares Outstanding 51.2M 39.4M 24.7M -- 24.5M 24.4M 24.3M --
Diluted Shares Outstanding 51.2M 39.4M 24.7M -- 24.5M 24.4M 24.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $26.70M $40.23M $53.50M
Short-Term Investments $81.31M $145.2M $23.47M
Cash & Short-Term Investments $108.0M $185.4M $76.97M
Accounts Receivable, Net -- $0 $1.03M
Total Current Assets $112.7M $188.6M $79.82M
Property, Plant & Equipment, Net $6.62M $6.37M $8.10M
Other Non-Current Assets $458K $267K $392K
Total Non-Current Assets $18.27M $20.95M $25.29M
Total Assets $130.9M $209.6M $105.1M
Accounts Payable $355K $1.12M $614K
Other Current Liabilities $73K -- --
Total Current Liabilities $13.09M $12.25M $12.23M
Other Non-Current Liabilities -- $73K $73K
Total Non-Current Liabilities $7.88M $10.69M $38.49M
Total Liabilities $20.97M $22.94M $50.72M
Total Debt (incl. Leases) $10.94M $14.35M $16.91M
Common Stock $3.0K $3.0K --
Retained Earnings -$330.5M -$246.7M -$181.3M
Accumulated Other Comp. Income $103K -$129K $308K
Total Stockholders' Equity $110.0M $186.6M -$162.0M
Total Equity $110.0M $186.6M -$162.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $61.23M $301.5M $20.95M $26.70M $25.51M $28.47M $30.40M $40.23M
Short-Term Investments $257.9M $47.94M $65.83M $81.31M $97.46M $113.9M $135.6M $145.2M
Cash & Short-Term Investments $319.1M $349.4M $86.80M $108.0M $123.0M $142.4M $166.0M $185.4M
Accounts Receivable, Net -- -- -- -- -- -- -- $0
Total Current Assets $326.2M $352.3M $88.74M $112.7M $129.5M $149.1M $170.0M $188.6M
Property, Plant & Equipment, Net $6.17M $5.67M $6.22M $6.62M $6.98M $6.89M $7.06M $6.37M
Other Non-Current Assets $1.31M $809K $458K $458K $418K $38K $13K $267K
Total Non-Current Assets $16.73M $16.36M $17.21M $18.27M $19.34M $20.32M $21.26M $20.95M
Total Assets $343.0M $368.6M $106.0M $130.9M $148.9M $169.4M $191.3M $209.6M
Accounts Payable $2.04M $1.39M $2.29M $355K $848K $1.22M $2.04M $1.12M
Other Current Liabilities -- -- -- $73K $73K $73K $73K --
Total Current Liabilities $16.41M $14.58M $10.88M $13.09M $11.12M $10.77M $12.20M $12.25M
Other Non-Current Liabilities -- -- -- -- -- -- -- $73K
Total Non-Current Liabilities $5.85M $6.55M $7.23M $7.88M $8.52M $9.58M $10.28M $10.69M
Total Liabilities $22.26M $21.13M $18.11M $20.97M $19.64M $20.35M $22.48M $22.94M
Total Debt (incl. Leases) $9.17M $9.85M $10.26M $10.94M $11.69M $13.22M $14.00M $14.35M
Common Stock $5.0K $5.0K $3.0K $3.0K $3.0K $3.0K $3.0K $3.0K
Retained Earnings -$407.9M -$379.1M -$354.1M -$330.5M -$309.8M -$288.2M -$267.0M -$246.7M
Accumulated Other Comp. Income -$1.25M -$21K -$18K $103K $87K $2.0K -- -$129K
Total Stockholders' Equity $320.7M $347.5M $87.85M $110.0M $129.2M $149.0M $168.8M $186.6M
Total Equity $320.7M $347.5M $87.85M $110.0M $129.2M $149.0M $168.8M $186.6M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31
Net Income -$83.86M -$65.37M -$28.72M
Depreciation & Amortization $2.60M $2.43M $2.27M
Stock-Based Compensation $6.82M $6.98M $7.05M
Change in Receivables $0 $1.03M -$510K
Change in Payables -$760K $519K -$408K
Operating Cash Flow -$76.75M -$55.03M -$47.43M
Capital Expenditure -$2.59M -$642K -$3.26M
Free Cash Flow -$79.34M -$55.67M -$50.69M
Purchases of Investments -$44.88M -$176.2M --
Sales & Maturities of Investments $110.9M $56.35M --
Investing Cash Flow $63.41M -$120.5M -$25.98M
Common Stock Issued $0 $166.5M --
Financing Cash Flow $9.0K $162.2M $24.39M
Net Change in Cash -$13.33M -$13.27M -$49.01M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$28.82M -$25.00M -$23.52M -$20.77M -$21.53M -$21.25M -$20.31M -$16.09M
Depreciation & Amortization $754K $692K $666K $666K $662K $641K $628K $614K
Stock-Based Compensation $2.80M $1.86M $1.59M $1.59M $1.63M $1.55M $2.05M $2.18M
Change in Receivables -- -- -- -- -- -- -- $569K
Change in Payables $506K -$780K $1.81M -$150K -$442K -$209K $41K -$82K
Operating Cash Flow -$28.45M -$20.36M -$20.95M -$14.73M -$19.20M -$22.98M -$19.84M -$14.65M
Capital Expenditure -$1.04M -$415K -$242K -$421K -$600K -$1.05M -$511K -$64K
Free Cash Flow -$29.49M -$20.77M -$21.19M -$15.15M -$19.80M -$24.04M -$20.35M -$14.71M
Purchases of Investments -$235.5M $0 -$6.44M -$7.54M -$12.74M -$6.07M -$18.52M -$14.85M
Sales & Maturities of Investments $24.81M $18.00M $22.00M $24.00M $29.62M $28.25M $29.00M $13.95M
Investing Cash Flow -$211.7M $17.59M $15.32M $16.04M $16.28M $21.12M $9.97M -$966K
Financing Cash Flow -$26K $283.3M -$112K -$121K -$37K -$72K $239K --
Net Change in Cash -$240.2M $280.5M -$5.75M $1.19M -$2.96M -$1.93M -$9.63M -$15.65M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31
Operating Margin -- -26805.6% -91.6%
Net Profit Margin -- -26045.0% -85.8%
Return on Equity (ROE) -76.3% -35.0% --
Return on Assets (ROA) -64.0% -31.2% -27.3%
Current Ratio 8.61x 15.39x 6.53x
Quick Ratio 8.25x 15.13x 6.38x
Debt to Equity 0.10x 0.08x --
Revenue Growth (YoY) -100.0% -99.3% --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -- -- -- -- -- -- -26806.4%
Net Profit Margin -- -- -- -- -- -- -- -26045.0%
Return on Equity (ROE) -30.6% -26.1% -99.1% -76.3% -61.3% -50.4% -42.5% -35.0%
Return on Assets (ROA) -28.6% -24.6% -82.2% -64.0% -53.2% -44.4% -37.5% -31.2%
Current Ratio 19.88x 24.16x 8.16x 8.61x 11.65x 13.84x 13.93x 15.39x
Quick Ratio 19.45x 23.96x 7.98x 8.25x 11.06x 13.22x 13.60x 15.13x
Debt to Equity 0.03x 0.03x 0.12x 0.10x 0.09x 0.09x 0.08x 0.08x
Source: SEC EDGAR CompanyFacts (CIK 0001817241) · from March 31, 2023 Data through September 30, 2026 · synced Nov 20, 2026, 05:44 UTC · Open in terminal